According to a newly published market research report by 24LifeSciences, global Bruton's Tyrosine Kinase (BTK) inhibitors market was valued at USD 6,941 million in 2024 and is projected to reach USD 9,622 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period. BTK inhibitors are small molecule therapeutics that selectively inhibit the Bruton's...

The diabetic retinopathy market is expanding steadily as the global burden of diabetes continues to rise, increasing the need for effective diagnosis and treatment of vision-related complications. Growing awareness of diabetic eye diseases, improvements in ophthalmic care, and the adoption of advanced therapeutic approaches are contributing to market growth. Healthcare providers are placing...

The global healthcare industry is experiencing a significant transformation as neurological disorders continue to rise at an alarming rate. Conditions such as Alzheimer’s disease and other forms of dementia are placing increasing pressure on healthcare systems worldwide. Rising Disease Burden and Treatment DemandThe growing prevalence of dementia across aging populations has intensified...

The global gastrointestinal drugs market is witnessing strong growth due to the increasing prevalence of digestive disorders, rising healthcare awareness, expanding biologics development, and growing pharmaceutical innovations. Gastrointestinal drugs are widely used to treat disorders affecting the digestive tract, including irritable bowel syndrome (IBS), ulcerative colitis, Crohn’s...

The global RNAi therapeutics market is gaining significant momentum as advancements in genetic medicine and molecular biology continue to transform the pharmaceutical landscape. RNA interference (RNAi) therapeutics represent a breakthrough approach in disease treatment by targeting and silencing specific genes responsible for disease progression. This innovative mechanism enables highly precise...

The United States is at the forefront of advancements in adult malignant glioma therapeutics, supported by a strong ecosystem of leading research institutions, pharmaceutical companies, and specialized cancer treatment centers. The rising incidence of aggressive brain tumors, increasing investment in precision oncology, and growing adoption of targeted therapies and immunotherapies are driving...

The Inflammatory Bowel Disease Treatment Market is witnessing significant growth due to the rising prevalence of chronic gastrointestinal disorders, increasing awareness regarding early diagnosis, and continuous advancements in biologic therapies. Inflammatory bowel disease (IBD), which primarily includes Crohn’s disease and ulcerative colitis, affects millions of individuals globally and...

The global mRNA sequencing market is witnessing remarkable expansion as healthcare systems, pharmaceutical companies, and research institutions increasingly adopt advanced sequencing technologies for disease diagnosis, precision medicine, and therapeutic development. mRNA sequencing has become an essential tool for transcriptome analysis, enabling researchers to study gene expression patterns,...

North America holds a substantial share of the cell therapy instrument market due to its well-established life sciences industry, increasing commercialization of cell-based therapies, and significant research and development activities. Growing demand for automated manufacturing platforms and advanced therapeutic solutions is further contributing to regional market expansion. The cell therapy...

The healthcare industry is undergoing a significant transformation with the adoption of advanced drug administration technologies. Smart drug delivery systems have emerged as a critical innovation, enabling precise, controlled, and patient-friendly medication delivery. These systems are designed to improve therapeutic outcomes, enhance patient compliance, reduce side effects, and optimize...